Sr. Manager, Clinical Finance BP
Einheit: CSL Behring
Jobkategorie: Finance
Jobfamilie: Finance Business Partner
Beschäftigungsart: Full Time
Location: Waltham, Massachusetts, United States
Arbeitgeberreferenz: R-293050
Stellenbeschreibung
The Opportunity:
As the Senior Manager, Clinical Finance Business Partner, you will report to the Director, Clinical Finance and serve as a key Finance Business Partner to Clinical Operations and the broader R&D organization. You will will own the financial management of the clinical study portfolio within assigned TAs, PSTs, assets, and/or studies, with primary responsibility for Clinical Operations external spend, including CROs, clinical vendors, FSP resources, and other study execution costs. You will will provide end-to-end financial oversight across the clinical study lifecycle, from study planning and scenario development through execution, forecasting, governance, and close-out. You will partner closely with Clinical Operations, TA Finance, PSTs, Study Leads, GPLs, CPMs, and other R&D stakeholders to translate clinical and operational assumptions into financial insights and ensure study financials are appropriately reflected in broader asset and portfolio decisions. Beyond core study financial management, upi will provide forward-looking analysis to support clinical development scenario planning, governance, Business Development due diligence, and continuous improvement across Clinical Finance and R&D Finance.
This is a hybrid role, requiring three (3) days of onsite work weekly. #LI-hybrid
The Role:
Clinical Study Financial Management & Business Partnering
- Own the financial management of assigned clinical study portfolios, providing end-to-end financial oversight throughout the study lifecycle.
- Maintain a comprehensive and forward-looking view of study financials, including approved budgets, actuals, commitments, accruals, forecasts, POs, vendor contracts/SOW, and FSP costs.
- Lead PST and Asset level budgeting, forecasting, month-end closing, accrual and prepayment activities, variance analysis, and financial reporting.
- Monitor financial performance against approved budgets and forecasts, proactively identifying and communicating key risks, opportunities, potential gaps, and changes in financial outlook.
- Partner closely with TA Study Leads, GPLs, CPMs, and Clinical Operations to understand study execution and ensure forecasts reflect current assumptions, including timelines, enrollment, site activation, geographic mix, vendor activities, and contractual commitments.
- Collaborate with TA Finance to ensure clinical study financials, assumptions, risks, opportunities, and scenarios are appropriately incorporated into the broader asset and R&D financial outlook.
- Provide clear financial insights and recommendations to support study, portfolio, and business decisions.
Financial Modeling, Scenario Planning & Decision Support
- Develop, enhance, and maintain robust clinical financial models to support study costing, scenario planning, and decision-making, with transparent assumptions, key cost drivers, and sensitivities.
- Lead financial analysis of clinical development scenarios, including alternative study designs, patient populations, enrollment assumptions, timelines, geographic/site strategies, study sequencing, and other key development assumptions.
- Translate clinical and operational scenarios into clear financial implications, sensitivities, risks, opportunities, and investment requirements.
- Provide financial analysis, modeling, and business cases to support PRISM and other R&D governance and investment decisions.
- Partner with Clinical Operations, Clinical Development, TA Finance, PSTs, and other stakeholders to ensure financial scenarios appropriately reflect clinical and operational strategies.
- Clearly communicate complex assumptions and financial implications to Finance and non-Finance stakeholders.
CRO & Vendor Financial Management
- Conduct regular financial reviews with CROs and other clinical study vendors, covering actuals, accruals, commitments, forecasts, change orders, and overall budget status.
- Review and track study work orders and unit-based charges, challenging activity assumptions, unit volumes, rates, and variances against contract, budget, and forecast.
- Assess the financial impact of contract amendments, change orders, and evolving study requirements and ensure these are appropriately reflected in forecasts.
- Partner with R&D contracts & outsourcing team, ensuring alignment among contracts, work orders, POs, invoices, budgets, and forecasts.
Business Development & Due Diligence
- Provide Clinical Finance support for Business Development and due diligence activities, with a focus on clinical development plans and associated costs.
- Develop and evaluate clinical development cost scenarios for potential external opportunities, including study designs, timelines, patient populations, geographic assumptions, and development pathways.
- Review and constructively challenge key assumptions and identify significant cost drivers, sensitivities, risks, and opportunities.
- Partner with Business Development Finance, and other BD project stakeholders to incorporate clinical development costs and scenarios into broader business cases and investment evaluations.
Process Improvement & Broader R&D Finance Contribution
- Proactively identify opportunities to simplify, standardize, automate, and improve Clinical Finance processes, tools, models, and reporting.
- Develop practical and scalable solutions to improve financial transparency, forecast accuracy, efficiency, and decision support.
- Collaborate across R&D Finance to share best practices, strengthen financial capabilities, and improve consistency across teams.
- Contribute to or lead cross-functional initiatives that improve Clinical Finance, R&D Finance, and broader R&D ways of working.
- Maintain a broad R&D perspective and proactively identify opportunities where Clinical Finance expertise can contribute to broader business decisions.
Your Skills & Abilities:
- Bachelor's degree in Finance, Accounting, Business, or a related discipline; MBA or advanced degree preferred.
- 7+ years of relevant Finance, FP&A, R&D Business Operations, or related experience, preferably within the pharmaceutical or biotechnology industry.
- Strong understanding of clinical-stage drug development and clinical trial financial management.
- Strong experience in budgeting, forecasting, accrual management, financial analysis, and financial modeling.
- Ability to translate clinical and operational assumptions into financial scenarios, insights, and recommendations to support business decisions.
- Strong business partnering, communication, and influencing skills, with the ability to collaborate effectively across Clinical Operations, R&D, Finance, and other functions.
- Strong analytical and problem-solving skills, with the ability to work independently, manage multiple priorities, and drive continuous improvement.
CSL Leadership / Behavioral Expectations
- Thinks Beyond – looks beyond current approaches and considers the broader business environment.
- Builds Bridges – proactively collaborates across businesses, functions, and teams.
- Unleashes Outcomes – demonstrates accountability and supports effective decision-making.
- Ignites Agility – embraces and helps drive effective change.
- Inspires the Future – connects day-to-day work with broader organizational direction.
Travel Requirements:
- Domestic and International travel may be required from time to time.
Über CSL Behring
CSL Behring ist ein weltweit führender Anbieter von Biotherapeutika, angetrieben von unserem Versprechen, Leben zu retten. Wir konzentrieren uns darauf, die Bedürfnisse der Patienten durch den Einsatz der neuesten Technologien zu erfüllen. Wir entdecken, entwickeln und liefern innovative Therapien für Menschen, die mit Erkrankungen in den Therapiebereichen Immunologie, Hämatologie, Herz-Kreislauf und Stoffwechsel, Atemwegserkrankungen und Transplantation leben. Wir nutzen drei strategische wissenschaftliche Plattformen der Plasmafraktionierung, der rekombinanten Proteintechnologie sowie der Zell- und Gentherapie, um kontinuierliche Innovation zu unterstützen und die Wege zu verfeinern, auf denen Produkte ungedeckte medizinische Bedürfnisse ansprechen und Patienten zu einem erfüllten Leben verhelfen können.
CSL Behring betreibt eines der weltweit größten Plasma-Sammelnetzwerke, CSL Plasma. Unsere Muttergesellschaft CSL mit Hauptsitz in Melbourne, Australien, beschäftigt 32.000 Mitarbeiter und liefert ihre lebensrettenden Therapien an Menschen in mehr als 100 Ländern.
Um mehr über CSL, CSL Behring, CSL Seqirus und CSL Vifor zu erfahren, besuchen Sie https://www.csl.com/ und CSL Plasma unter https://www.cslplasma.com/.
Unsere Vorteile
Weitere Informationen zu den CSL-Vorteilen finden Sie unter How CSL Supports Your Well-being | CSL.
Sie gehören zu CSL
Bei CSL stehen Inklusion und Zugehörigkeit im Mittelpunkt unserer Mission und unserer Identität. Sie treiben unsere Innovation Tag für Tag an. Indem wir unsere Unterschiede feiern und eine Kultur der Neugier und Empathie schaffen, sind wir in der Lage, unsere Patienten und Spender besser zu verstehen und mit ihnen in Kontakt zu treten, starke Beziehungen zu unseren Stakeholdern zu pflegen und eine vielfältige Belegschaft aufrechtzuerhalten, die unser Unternehmen und unsere Branche in die Zukunft führen wird.
Um mehr über Inklusion und Zugehörigkeit zu erfahren, besuchen Sie https://www.csl.com/careers/inclusion-and-belonging
Arbeitgeber der Chancengleichheit
CSL ist ein Arbeitgeber der Chancengleichheit (Equal Opportunity Employer). Wenn Sie eine Person mit einer Behinderung sind und eine angemessene Vorkehrung für einen Teil des Bewerbungsprozesses benötigen, besuchen Sie bitte https://www.csl.com/accessibility-statement.